These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
412 related articles for article (PubMed ID: 24922680)
1. Intratumoral but not peritumoral lymphatic vessel density measured by D2-40 expression predicts poor outcome in gastric cancer--ROC curve analysis to find cut-off point. Donizy P; Rudno-Rudzinska J; Halon A; Dziegala M; Kabarowski J; Frejlich E; Dziegiel P; Kielan W; Matkowski R Anticancer Res; 2014 Jun; 34(6):3113-8. PubMed ID: 24922680 [TBL] [Abstract][Full Text] [Related]
2. Increased intratumoral lymphatic vessel density correlates with lymph node metastasis in early gastric carcinoma. Lee K; Park DJ; Choe G; Kim HH; Kim WH; Lee HS Ann Surg Oncol; 2010 Jan; 17(1):73-80. PubMed ID: 19777179 [TBL] [Abstract][Full Text] [Related]
3. Peritumoral lymphatic microvessel density associated with tumor progression and poor prognosis in gastric carcinoma. Coşkun U; Akyürek N; Dursun A; Yamaç D J Surg Res; 2010 Nov; 164(1):110-5. PubMed ID: 19628230 [TBL] [Abstract][Full Text] [Related]
4. Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases. Wang XL; Fang JP; Tang RY; Chen XM BMC Cancer; 2010 Jun; 10():299. PubMed ID: 20565772 [TBL] [Abstract][Full Text] [Related]
5. High density of peritumoral lymphatic vessels measured by D2-40/podoplanin and LYVE-1 expression in gastric cancer patients: an excellent prognostic indicator or a false friend? Rudno-Rudzinska J; Kielan W; Grzebieniak Z; Dziegiel P; Donizy P; Mazur G; Knakiewicz M; Frejlich E; Halon A Gastric Cancer; 2013 Oct; 16(4):513-20. PubMed ID: 23238856 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of Lymphatic Vessel Density Detected by D2-40 and Its Relation to Claudin-4 Expression in Prostatic Adenocarcinoma. Radi DA; Abd-Elazeem MA Int J Surg Pathol; 2016 May; 24(3):219-26. PubMed ID: 26464161 [TBL] [Abstract][Full Text] [Related]
7. Intratumoral lymphatic vessel density in vulvar squamous cell carcinomas: a possible association with favorable prognosis. Goes RS; Carvalho JP; Almeida BG; Bacchi CE; Goes JC; Calil MA; Baracat EC; Carvalho FM Int J Gynecol Pathol; 2012 Jan; 31(1):8-14. PubMed ID: 22123718 [TBL] [Abstract][Full Text] [Related]
8. Lymphatic vessel density as a prognostic marker in clinical stage I endocervical adenocarcinoma. Saad RS; Ismiil N; Ghorab Z; Nofech-Mozes S; Dubé V; Covens A; Khalifa MA Int J Gynecol Pathol; 2010 Jul; 29(4):386-93. PubMed ID: 20567154 [TBL] [Abstract][Full Text] [Related]
9. Clinical significance of peritumoral lymphatic vessel density and lymphatic vessel invasion detected by D2-40 immunostaining in FIGO Ib1-IIa squamous cell cervical cancer. Xiong Y; Cao LP; Rao HL; Cai MY; Liang LZ; Liu JH Cell Tissue Res; 2012 Jun; 348(3):515-22. PubMed ID: 22492093 [TBL] [Abstract][Full Text] [Related]
10. The lymphatic system in clinically localized urothelial carcinoma of the bladder: morphologic characteristics and predictive value. Bolenz C; Auer M; Ströbel P; Heinzelbecker J; Schubert C; Trojan L Urol Oncol; 2013 Nov; 31(8):1606-14. PubMed ID: 22503575 [TBL] [Abstract][Full Text] [Related]
11. Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix. Gombos Z; Xu X; Chu CS; Zhang PJ; Acs G Clin Cancer Res; 2005 Dec; 11(23):8364-71. PubMed ID: 16322297 [TBL] [Abstract][Full Text] [Related]
12. Intratumoral lymphatics and lymphatic vessel invasion detected by D2-40 are essential for lymph node metastasis in bladder transitional cell carcinoma. Ma Y; Hou Y; Liu B; Li X; Yang S; Ma J Anat Rec (Hoboken); 2010 Nov; 293(11):1847-54. PubMed ID: 20730866 [TBL] [Abstract][Full Text] [Related]
13. Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients. Zhao YC; Ni XJ; Li Y; Dai M; Yuan ZX; Zhu YY; Luo CY World J Surg Oncol; 2012 Aug; 10():165. PubMed ID: 22906075 [TBL] [Abstract][Full Text] [Related]
14. Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti-podoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph node metastases. Adachi Y; Nakamura H; Kitamura Y; Taniguchi Y; Araki K; Shomori K; Horie Y; Kurozawa Y; Ito H; Hayashi K Pathol Int; 2007 Apr; 57(4):171-7. PubMed ID: 17316411 [TBL] [Abstract][Full Text] [Related]
15. Importance of lymph vessels in gastric cancer: a prognostic indicator in general and a predictor for lymph node metastasis in early stage cancer. Nakamura Y; Yasuoka H; Tsujimoto M; Kurozumi K; Nakahara M; Nakao K; Kakudo K J Clin Pathol; 2006 Jan; 59(1):77-82. PubMed ID: 16394285 [TBL] [Abstract][Full Text] [Related]
16. Lymphatic vessel density and lymph node metastasis in prostate cancer. Zeng Y; Opeskin K; Horvath LG; Sutherland RL; Williams ED Prostate; 2005 Nov; 65(3):222-30. PubMed ID: 15948136 [TBL] [Abstract][Full Text] [Related]
17. D2-40 immunoreactivity in penile squamous cell carcinoma: a marker of aggressiveness. Minardi D; d'Anzeo G; Lucarini G; Filosa A; Zizzi A; Simonetti O; Polito M; Offidani AM; Di Primio R; Montironi R; Muzzonigro G Hum Pathol; 2011 Nov; 42(11):1596-602. PubMed ID: 21497368 [TBL] [Abstract][Full Text] [Related]
18. Detection of lymphovascular invasion by D2-40 (podoplanin) immunoexpression in endometrial cancer. Weber SK; Sauerwald A; Pölcher M; Braun M; Debald M; Serce NB; Kuhn W; Brunagel-Walgenbach G; Rudlowski C Int J Gynecol Cancer; 2012 Oct; 22(8):1442-8. PubMed ID: 22964524 [TBL] [Abstract][Full Text] [Related]
19. Lymphangiogenesis in gastric carcinoma correlates with prognosis. Gao P; Zhou GY; Zhang QH; Su ZX; Zhang TG; Xiang L; Wang Y; Zhang SL; Mu K J Pathol; 2009 Jun; 218(2):192-200. PubMed ID: 19224540 [TBL] [Abstract][Full Text] [Related]
20. Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer. Nakamura Y; Yasuoka H; Tsujimoto M; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K Breast Cancer Res Treat; 2005 May; 91(2):125-32. PubMed ID: 15868440 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]